Spinraza is a medication used in children (including newborns) and adults to treat spinal muscular atrophy. Treatment begins with four loading doses, followed by one maintenance dose every 4 months.

Spinraza (nusinersen) is a brand-name injection prescribed for spinal muscular atrophy in adults and children. As with other drugs, Spinraza can cause side effects, such as fever, headache, and ...

DEVOTE will evaluate the safety and potential for even greater efficacy of a higher dose of SPINRAZA in the treatment of spinal muscular atrophy (SMA) Well-established safety profile and proven ...

Ana Memedovich’s son, Mikhail, started receiving Biogen’s treatment for spinal muscular atrophy (SMA) in the spring of 2017, just months after the product was approved. Over the next few years, ...

(RTTNews) - Biogen Inc. (BIIB) announced that the European Commission has granted marketing authorisation for a high-dose regimen of SPINRAZA, comprised of 50 mg/5 mL and 28 mg/5 mL doses, for 5q ...

The approval was anchored on data from the pivotal DEVOTE study that investigated the efficacy and safety of the High Dose Regimen of SPINRAZA in treatment-naïve and previously treated SPINRAZA ...

When Biogen launched its highly anticipated spinal muscular atrophy (SMA) drug Spinraza, its $125,000-per-injection list price raised questions of whether there would be a payer backlash. Those ...

Two New Hyde Park sisters with an incurable condition are finding hope in a revolutionary new treatment. Lisa Panzica, 40, and Laura Chamaidan, 38, are some of the first patients in the state to ...

Spinraza (nusinersen) is a brand-name drug that’s prescribed for spinal muscular atrophy (SMA) in adults and children. Spinraza comes as a spinal injection that’s given by a healthcare professional ...